Related Experiment Video
Updated: May 7, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Treatment of localized sarcomas
Alessandro Gronchi1, Chandrajit P Raut
1Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan 20133, Italy.
Hematology/Oncology Clinics of North America
|October 8, 2013
Summary
Surgery is the main cure for localized soft tissue sarcomas and gastrointestinal stromal tumors. Treatment success depends on sarcoma type and location, impacting recurrence and prognosis.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Background:
- Localized adult soft tissue sarcomas and gastrointestinal stromal tumors are best treated with surgery.
- Over 50 distinct histologic types of soft tissue sarcomas exist, each with unique recurrence patterns and prognoses.
- Treatment strategies must account for histologic type and tumor location.
Purpose of the Study:
- To review the surgical management of localized adult soft tissue sarcomas and gastrointestinal stromal tumors.
- To highlight the variability in surgical principles and treatment sensitivity based on sarcoma characteristics.
- To provide a comprehensive overview of factors influencing recurrence and prognosis.
Main Methods:
- Literature review of surgical management for soft tissue sarcomas and gastrointestinal stromal tumors.
- Analysis of histologic variations and their impact on treatment.
- Discussion of anatomic location considerations in surgical planning.
Main Results:
- Surgery is the sole potentially curative option for these localized tumors.
- Histologic type significantly influences recurrence patterns and patient prognosis.
- Anatomic location and histologic subtype dictate the efficacy of locoregional and systemic therapies.
Conclusions:
- Surgical management requires tailored approaches based on specific sarcoma histology and location.
- Understanding histologic variations is crucial for optimizing treatment and predicting outcomes.
- Effective management necessitates a detailed consideration of tumor characteristics and their implications for recurrence and prognosis.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...